The DOI matches its Crossref record; 427 of the 427 references it cites were found in a registry or an index.
Androgens and Coronary Artery Disease
Abstract
A significant and independent association between endogenous testosterone (T) levels and coronary events in men and women has not been confirmed in large prospective studies, although cross-sectional data have suggested coronary heart disease can be associated with low T in men. Hypoandrogenemia in men and hyperandrogenemia in women are associated with visceral obesity; insulin resistance; low high-density lipoprotein (HDL) cholesterol (HDL-C); and elevated triglycerides, low-density lipoprotein cholesterol, and plasminogen activator type 1. These gender differences and confounders render the precise role of endogenous T in atherosclerosis unclear. Observational studies do not support the hypothesis that dehydroepiandrosterone sulfate deficiency is a risk factor for coronary artery disease. The effects of exogenous T on cardiovascular mortality or morbidity have not been extensively investigated in prospective controlled studies; preliminary data suggest there may be short-term improvements in electrocardiographic changes in men with coronary artery disease. In the majority of animal experiments, exogenous T exerts either neutral or beneficial effects on the development of atherosclerosis. Exogenous androgens induce both apparently beneficial and deleterious effects on cardiovascular risk factors by decreasing serum levels of HDL-C, plasminogen activator type 1 (apparently deleterious), lipoprotein (a), fibrinogen, insulin, leptin, and visceral fat mass (apparently beneficial) in men as well as women. However, androgen-induced declines in circulating HDL-C should not automatically be assumed to be proatherogenic, because these declines may instead reflect accelerated reverse cholesterol transport. Supraphysiological concentrations of T stimulate vasorelaxation; but at physiological concentrations, beneficial, neutral, and detrimental effects on vascular reactivity have been observed. T exerts proatherogenic effects on macrophage function by facilitating the uptake of modified lipoproteins and an antiatherogenic effect by stimulating efflux of cellular cholesterol to HDL. In conclusion, the inconsistent data, which can only be partly explained by differences in dose and source of androgens, militate against a meaningful assessment of the net effect of T on atherosclerosis. Based on current evidence, the therapeutic use of T in men need not be restricted by concerns regarding cardiovascular side effects. Available data also do not justify the uncontrolled use of T or dehydroepiandrosterone for the prevention or treatment of coronary heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 427
Herrington, D. M., Gordon, G. B., Achuff, S. C., Trejo, J. F., Weisman, H. F., Kwiterovich, P. O., & Pearson, T. A. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80334-1 · Cited by 147
Obesity, lipids, cardiovascular risk, and androgen excess
Wild, R. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80056-4 · Cited by 145
Kamischke, A., Venherm, S., Plöger, D., von Eckardstein, S., & Nieschlag, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7057 · Cited by 145
Serum Leptin Concentrations in Women with Polycystic Ovary Syndrome
Rouru, J., Anttila, L., Koskinen, P. J., Penttilä, T.-A., Irjala, K. M. A., Huupponen, R., & Koulu, M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.3996 · Cited by 143
Wilson, J. D., & Roehrborn, C. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6206 · Cited by 143
Murphy, J. G., & Khalil, R. A. (1999) · PubMed · Cited by 142
Fujimoto, R., Morimoto, I., Morita, E., Sugimoto, H., Ito, Y., & Eto, S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90025-6 · Cited by 141
Hanke, H., Lenz, C., Hess, B., Spindler, K., & Weidemann, W. M. (2001) · Circulation · doi:10.1161/01.cir.103.10.1382 · Cited by 141
Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease
Ong, P. J. L., Patrizi, G., Chong, W. C. F., Webb, C. M., Hayward, C., & Collins, P. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00630-x · Cited by 140
Effects of androgens on haemostasis
Winkler, U. H. (1996) · Maturitas · doi:10.1016/s0378-5122(96)82004-4 · Cited by 139
Arlt, W., Callies, F., Koehler, I., van Vlijmen, J. C., Faßnacht, M., Strasburger, C. J., Seibel, M. J., Huebler, D., Ernst, M. E., Oettel, M., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7974 · Cited by 139
SEX HORMONES, INSULIN, LIPIDS, AND PREVALENT ISCHEMIC HEART DISEASE
Lichtenstein, M. J., YARNELL, J. W. G., Elwood, P. C., Beswick, A. D., Sweetnam, P. M., Marks, V., Teale, D., & Riad-Fahmy, D. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114704 · Cited by 138
Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages
Schmidt, M., Kreutz, M. P., Löffler, G., Schölmerich, J., & Straub, R. H. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1640161 · Cited by 138
Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort
Phillips, G. B., Castelli, W. P., Abbott, R. D., & McNamara, P. M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91078-1 · Cited by 137
Honda, H., Unemoto, T., & Kogo, H. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1232 · Cited by 136
Arad, Y., Badimón, J. J., Badimón, L., Hembree, W. C., & Ginsberg, H. N. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.2.159 · Cited by 134
Androgen Replacement in Women: A Commentary
Davis, S. R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5802 · Cited by 132
Zitzmann, M., Brune, M., Kornmann, B., Gromoll, J., von Eckardstein, S., von Eckardstein, A., & Nieschlag, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7889 · Cited by 131
17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice
Elhage, R., Arnal, J., Pieraggi, M. T., Duverger, N., Fiévet, C., Faye, J., & Bayard, F. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2679 · Cited by 129
Usefulness of sex steroid hormone levels in predicting coronary artery disease in men
Cauley, J. A., Gutai, J. P., Kuller, L. H., & Dai, W. S. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91021-6 · Cited by 128
Danenberg, H. D., Alpert, G., Lustig, S., & Ben‐Nathan, D. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2275 · Cited by 127
Bruck, B., Brehme, U., Gugel, N., Hanke, S., Finking, G., Lutz, C., Benda, N., Schmahl, F. W., Haasis, R., & Hanke, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2192 · Cited by 127
Physiologic Testosterone Levels in Normal Men Suppress High-Density Lipoprotein Cholesterol Levels
Bagatell, C. J., Knopp, R. H., Vale, W., Rivier, J. E., & Bremner, W. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-967 · Cited by 126
Eich, D., Nestler, J. E., Johnson, D. E., Dworkin, G. H., Ko, D., Wechsler, A. S., & Hess, M. L. (1993) · Circulation · doi:10.1161/01.cir.87.1.261 · Cited by 126
Akishita, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06023-6 · Cited by 126
Cardiovascular Risk In Women With Polycystic Ovary Syndrome
Talbott, E. O., Zborowski, J. V., Sutton-Tyrrell, K., McHugh-Pemu, K. P., & Guzick, D. S. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70189-3 · Cited by 126
Androgen Deficiency in Women with Hypopituitarism
Miller, K. K., Sesmilo, G., Schiller, A., Schoenfeld, D., Burton, S., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7246 · Cited by 124
Bhasin, S., Swerdloff, R. S., Steiner, B., Peterson, M., Meridores, T., Galmirini, M., Pandian, M. R., Goldberg, R. B., & Berman, N. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.1.1727832 · Cited by 123
Dehydroepiandrosterone Sulfate and Mortality in Elderly Men and Women
Trivedi, D. P., & Khaw, K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7838 · Cited by 122
Anawalt, B. D., Bebb, R. A., Bremner, W. J., & Matsumoto, A. M. (1999) · Journal of Andrology · doi:10.1002/j.1939-4640.1999.tb02535.x · Cited by 120
Frazer, K. A., Narla, G., Zhang, J. L., & Rubin, E. M. (1995) · Nature Genetics · doi:10.1038/ng0495-424 · Cited by 120
Wu, F. C. W., Farley, T. M. M., Peregoudov, A., & Waites, G. M. H. (1996) · Fertility and Sterility · doi:10.1016/s0015-0282(16)58166-7 · Cited by 120
Self-citationInsulin-sensitizing agents in polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02156 · Cited by 119
Dehydroepiandrosterone Sulfate Does Not Predict Cardiovascular Death in Postmenopausal Women
Barrett-Connor, E. L., & Goodman‐Gruen, D. (1995) · Circulation · doi:10.1161/01.cir.91.6.1757 · Cited by 118
LaCroix, A. Z., Yano, K., & REED, D. M. (1992) · Circulation · doi:10.1161/01.cir.86.5.1529 · Cited by 118
Dahlgren, E., Landin, K., Krotkiewski, M., Holm, G., & Janson, P. O. (1998) · Human Reproduction · doi:10.1093/humrep/13.10.2706 · Cited by 118
Wu, F. C. W., Balasubramanian, R., Mulders, T. M. T., & Bennink, H. J. T. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5412 · Cited by 117
Self-citationAndrogen and progestagen effects on plasma lipids
Bagatell, C. J., & Bremner, W. J. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80016-6 · Cited by 117
Howell, S. J., Radford, J. A., Adams, J. E., Smets, E. M. A., Warburton, R., & Shalet, S. M. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01297.x · Cited by 117
Snyder, P. J., Peachey, H., Berlin, J. A., Rader, D. J., Usher, D. C., Loh, L., Hannoush, P., Dlewati, A., Holmes, J. H., Santanna, J., et al. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00813-0 · Cited by 117
Mitchell, L. E., Sprecher, D. L., Borecki, I. B., Rice, T., Laskarzewski, P. M., & Rao, D. C. (1994) · Circulation · doi:10.1161/01.cir.89.1.89 · Cited by 116
Dobs, A. S., Schrott, H. G., Davidson, M. H., Bays, H. E., Stein, E. A., Kush, D., Wu, M., Mitchel, Y., & Illingworth, R. (2000) · Metabolism · doi:10.1053/meta.2000.7716a · Cited by 116
Cardiovascular Actions of Estrogens in Men
Sudhir, K., & Komesaroff, P. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5954 · Cited by 115
Kimura, M., Tanaka, S., Yamada, Y., Kiuchi, Y., Yamakawa, T., & Sekihara, H. (1998) · Endocrinology · doi:10.1210/endo.139.7.6118 · Cited by 115
Goldberg, R. B., Rabin, D., ALEXANDER, A. N., Doelle, G. C., & Getz, G. S. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-203 · Cited by 114
Plasminogen activator inhibitor in plasma is related to testosterone in men
Caron, P. J., Bennet, A., Camaré, R., et al. (1989) · Metabolism · doi:10.1016/0026-0495(89)90014-0 · Cited by 114
Salehian, B., Wang, C., Alexander, G. M., Davidson, T., McDonald, V., Berman, N., Dudley, R. E., Ziel, F. H., & Swerdloff, R. S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530600 · Cited by 114
Mendoza, S. G., Zerpa, A., Carrasco, H., Colmenares, O., Rangel, A., Gartside, P. S., & Kashyap, M. L. (1983) · PubMed · Cited by 114
Moriyama, Y., Yasue, H., Yoshimura, M., Mizuno, Y., Nishiyama, K., Tsunoda, R., Kawano, H., Kugiyama, K., Ogawa, H., Saito, Y., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6568 · Cited by 109
Fatty acids, hyperinsulinemia, and insulin resistance: which comes first?
Björntorp, P. A. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199405030-00003 · Cited by 108
Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?
von Eckardstein, A., & Assmann, G. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00010 · Cited by 108
Wu, F. C. W., Farley, T. M. M., Peregoudov, A., & Waites, G. M. H. (1996) · PubMed · Cited by 107
Self-citationEffects of Methyltestosterone on Insulin Secretion and Sensitivity In Women1
Diamond, M. P., Grainger, D. W., Connolly-Diamond, M., Sherwin, R. S., & DeFronzo, R. A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5333 · Cited by 106
Endogenous sex hormones: Impact on lipids, lipoproteins, and insulin
Haffner, S. M., & Valdez, R. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80058-8 · Cited by 105
Padgett, D. A., & Loria, R. M. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00244-0 · Cited by 105
Legrain, S., Massien, C., Lahlou, N., Roger, M., Debuire, B., Diquet, B., Châtellier, G., Azizi, M., Faucounau, V., Porchet, H. C., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6805 · Cited by 105
Sz, W., & Xz, W. (1993) · PubMed · Cited by 104
Nilsson, C., Niklasson, M., Eriksson, E., Björntorp, P., & Holmäng, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1353 · Cited by 103
Clinical Trial of Transdermal Testosterone and Oral Levonorgestrel for Male Contraception
Büchter, D., von Eckardstein, S., von Eckardstein, A., Kamischke, A., Simoni, M., Behre, H. M., & Nieschlag, E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5594 · Cited by 103
Contoreggi, C. S., Blackman, M. R., Andres, R., Muller, D. C., Lakatta, E. G., Fleg, J. L., & Harman, S. M. (1990) · Journal of Andrology · doi:10.1002/j.1939-4640.1990.tb00178.x · Cited by 102
Hämäläinen, E. K., Adlercreutz, H., Ehnholm, C., & Puska, P. (1986) · Metabolism · doi:10.1016/0026-0495(86)90011-9 · Cited by 102
Bayard, F., Clamens, S., Meggetto, F., Blaes, N., Delsol, G., & Faye, J. (1995) · Endocrinology · doi:10.1210/endo.136.4.7895662 · Cited by 101
Teoh, H., Quan, A., Leung, S. W. S., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703164 · Cited by 101
Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study.
YARNELL, J. W. G., Beswick, A. D., Sweetnam, P. M., & Riad-Fahmy, D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.517 · Cited by 101
Estradiol attenuates directed migration of vascular smooth muscle cells in vitro.
Kolodgie, F. D., Jacob, A., Wilson, P. S., Carlson, G. C., Farb, A. A., Verma, A., & Virmani, R. (1996) · Europe PMC (PubMed Central) · Cited by 100
Eri, L. M., Urdal, P., & Bechensteen, A. G. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67239-2 · Cited by 100
Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study
Hautanen, A., Mänttäri, M., Manninen, V., Tenkanen, L., Huttunen, J. K., Frick, M. H., & Adlercreutz, H. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90049-3 · Cited by 100
Jansson, J.-H., Nilsson, T., & Johnson, O. (1998) · Heart · doi:10.1136/hrt.80.4.334 · Cited by 100
Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen
Hayashi, T., Esaki, T., Muto, E., Kano, H., Asai, Y., Thakur, N. K., Sumi, D., Jayachandran, M., & Iguchi, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.782 · Cited by 99
Sex Hormone-Binding Protein, Hyperinsulinemia, Insulin Resistance and Noninsulin-Dependent Diabetes
Haffner, S. M. (2008) · Hormone Research · doi:10.1159/000184794 · Cited by 99
Haemostatic Effects of Supraphysiological Levels of Testosterone in Normal Men
Anderson, R. A., Ludlam, C. A., & Wu, F. C. W. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649799 · Cited by 98
Self-citationHemostatic and metabolic variables in women with polycystic ovary syndrome
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., Lindstedt, G., & Tengborn, L. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90386-7 · Cited by 98
Mattsson, L., Cullberg, G., Hamberger, L., Samsioe, G., & Silfverstolpe, G. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48142-2 · Cited by 98
Arterial Reactivity Is Enhanced in Genetic Males Taking High Dose Estrogens
McCrohon, J. A., Walters, W. A. W., Robinson, J. T. C., McCredie, R. J., Turner, L., Adams, M. R., Handelsman, D. J., & Celermajer, D. S. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00063-6 · Cited by 96
Bagatell, C. J., Knopp, R. H., Rivier, J., & Bremner, W. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.4.8157711 · Cited by 95
BEN‐HUR, H., Mor, G., Insler, V., Blickstein, I., Amir-Zaltsman, Y., Sharp, A., Globerson, A., & Kohen, F. (1995) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1995.tb00965.x · Cited by 93
Breier, C., Drexel, H., Lisch, H. ‐., Mühlberger, V., Herold, M., Knapp, E., & Braunsteiner, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92313-x · Cited by 93
Hutchison, S. J., Sudhir, K., Chou, T. M., Sievers, R. E., Zhu, B., Sun, Y., DEEDWANIA, P. C., Glantz, S. A., Parmley, W. W., & Chatterjee, K. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00570-0 · Cited by 92
Sorva, R., Kuusi, T., Taskinen, M., Perheentupa, J., & Nikkilä, E. A. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90014-7 · Cited by 92
Behre, H. M., Böckers, A., Schlingheider, A., & Nieschlag, E. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02475.x · Cited by 91
Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
Glueck, C. J., Glueck, H. I., Stroop, D. M., Speirs, J., Hamer, T., & Tracy, T. (1993) · PubMed · Cited by 90
Cardiovascular Toxicity of Anabolic Steroids
Rockhold, R. W. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.002433 · Cited by 90
Dehydroepiandrosterone Sulphate (DHEAS) in the Oldest Old, Aged 85 and Overa
Birkenhäger‐Gillesse, E. G., Derksen, J. J. L., & Lagaay, A. M. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56858.x · Cited by 89
GRAF, M. J., RICHARDS, C. J., BROWN, V., MEISSNER, L., & DUNAIF, A. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00472.x · Cited by 89
Acute and Nongenomic Effects of Testosterone on Isolated and Perfused Rat Heart
Ceballos, G. M., Lauro, F., Rubio‐Gayosso, I., Gallo, G. M., García, A., Martinez, A., Yañez, R., Pérez, J., Morato, T., & Chamorro, G. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199905000-00003 · Cited by 89
Geary, G. G., Krause, D. N., & DUCKLES, S. P. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.2.h610 · Cited by 89
Cox, B. S., & Robinson, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92230-8 · Cited by 89
Moorjani, S., Dupont, A., Labrie, F., Lupien, P.-J., Gagné, C., Brun, D., GIGUÉRE, M., Bélanger, A., & Cusan, L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-314 · Cited by 88
Kamischke, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.303 · Cited by 88
Hergenç, G., Schulte, H., Assmann, G., & von Eckardstein, A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00027-1 · Cited by 87
TESTOSTERONE PROPIONATE THERAPY IN ONE HUNDRED CASES OF ANGINA PECTORIS
Lesser, M. A. (1946) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-6-8-549 · Cited by 87
Arslanian, S. A. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.10.3213 · Cited by 87
Testosterone and risk factors for cardiovascular disease in men.
Barrett-Connor, E. L. (1995) · PubMed · Cited by 86
Metabolism of oxidized LDL by macrophages
Jessup, W., & Kritharides, L. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00005 · Cited by 86
Decreased Androgen Levels and Obesity in Men
Vermeulen, A. (1996) · Annals of Medicine · doi:10.3109/07853899608999068 · Cited by 86
Testosterone increases thromboxane A2 receptors in cultured rat aortic smooth muscle cells.
Masuda, A., Mathur, R. S., & Halushka, P. V. (1991) · Circulation Research · doi:10.1161/01.res.69.3.638 · Cited by 85
Sex hormones and lipoprotein metabolism
Sacks, F. M., & Walsh, B. W. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199405030-00012 · Cited by 84
Feldman, H. A., Johannes, C. B., McKinlay, J. B., & Longcope, C. (1998) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00199-3 · Cited by 84
Dobs, A. S., Bachorik, P. S., Arver, S., Meikle, A. W., Sanders, S. W., Caramelli, K. E., & Mazer, N. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7285 · Cited by 83
Androgen Deficiency in Women with Hypopituitarism
Miller, K. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.561 · Cited by 83
Matsuda, K., Ruff, A. L., Morinelli, T. A., Mathur, R. S., & Halushka, P. V. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.267.3.h887 · Cited by 82
Heller, R. F., Wheeler, M. J., Micallef, J., Miller, N. E., & Lewis, B. (1983) · European Journal of Endocrinology · doi:10.1530/acta.0.1040253 · Cited by 81
Hemostatic and metabolic variables in women with polycystic ovary syndrome
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., Lindstedt, G., & Tengborn, L. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56575-3 · Cited by 81
Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate: Their Relation to Cardiovascular Disease
Nafziger, A. N., Herrington, D. M., & Bush, T. L. (1991) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036071 · Cited by 80
Larsen, B. A., Nordestgaard, B. G., Stender, S., & Kjeldsen, K. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90053-w · Cited by 79
Testosterone enanthate at a dose of 200 mg/week decreases HDL‐cholesterol levels in healthy men
Meriggiola, M. C., Marcovina, S. M., Paulsen, C. A., & Bremner, W. J. (1995) · International Journal of Andrology · doi:10.1111/ijan.1995.18.5.237 · Cited by 79
Elbers, J. M. H., de Jong, S., Teerlink, T., Asscheman, H., Seidell, J. C., & Gooren, L. J. G. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90146-4 · Cited by 78
Pasquali, R., Macor, C., Vicennati, V., Iasio, F. R. D., Mesini, P., Boschi, S., Casimirri, F., & Vettor, R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90189-x · Cited by 77
Jockenhövel, F., Bullmann, C., Schubert, M., Vogel, E., Reinhardt, W., REINWEIN, D., Müller‐Wieland, D., & Krone, W. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90056-2 · Cited by 77
CARDIOVASCULAR CONSEQUENCES OF POLYCYSTIC OVARY SYNDROME
Amowitz, L. L., & Sobel, B. E. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70079-7 · Cited by 77
UYANIK, B. S., ARI, Z., GÜMÜS, B., YIGITOGLU, M. R., & ARSLAN, T. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.73 · Cited by 75
Dehydroepiandrosterone and coronary atherosclerosis
HERRINGTON, D. M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17387.x-i1 · Cited by 75
SOWINSKASRZEDNICKA, J., Zgliczyński, S., Ciświcka-Sznajderman, M., Srzednicki, M., Soszynski, P. A., Biernacka, M., Woroszylska, M., RUZO, W., & SADOWSKI, Z. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90124-x · Cited by 75
Barrett-Connor, E. L., & Khaw, K. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171116 · Cited by 75
Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women
Diamond, M. P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.12.4420 · Cited by 75
Su, W., Campos, H., Judge, H., Walsh, B. W., & Sacks, F. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5116 · Cited by 74
Phillips, G. B., Yano, K., & Stemmermann, G. N. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90018-2 · Cited by 74
Zmuda, J. M., Fahrenbach, M. C., Younkin, B., Bausserman, L., Terry, R. B., Catlin, D. H., & Thompson, P. D. (1993) · Metabolism · doi:10.1016/0026-0495(93)90101-s · Cited by 74
Relationship Between Sex Hormones, Myocardial Infarction, and Occlusive Coronary Disease
Luria, M. H. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340140044011 · Cited by 72
Abnormal hormone levels in men with coronary artery disease.
Zumoff, B., Troxler, R. G., O'Connor, J., Rosenfeld, R. S., Kream, J., Levin, J., Hickman, J. R., Sloan, A., Walker, W. J., Cook, R. L., et al. (1982) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.2.1.58 · Cited by 71
Dehydroepiandrosterone Inhibits Human Platelet Aggregation in Vitro and in Vivoa
Jesse, R. L., Loesser, K. E., Eich, D., Qian, Y. Z., Hess, M. L., & Nestler, J. E. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17388.x-i1 · Cited by 71
Testosterone Propionate in the Treatment of Angina Pectoris
HAMM, L. (1942) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-2-5-325 · Cited by 70
Testosterone decreases lipoprotein(a) in men
Zmuda, J. M., Thompson, P. D., Dickenson, R., & Bausserman, L. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00174-9 · Cited by 70
Özata, M., Yıldırımkaya, M., Bulur, M., Yılmaz, K. N., Bolu, E., Corakci, A., & Gündoğan, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784099 · Cited by 70
Marcovina, S. M., Lippi, G., Bagatell, C. J., & Bremner, W. J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05756-0 · Cited by 69
Zhu, X., Bonet, B., & Knopp, R. H. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70462-9 · Cited by 69
Yang, X., Jing, T., Resnick, L. M., & Phillips, G. B. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.4.467 · Cited by 69
Experience With Testosterone Replacement in the Elderly
Tenover, J. L. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(19)30648-2 · Cited by 69
Secretion of Bioactive Interleukin 1 by Rat Testicular Macrophages In Vitro
Hayes, R. B., Chalmers, S. A., Nikolic‐Paterson, D. J., et al. (1996) · Journal of Andrology · doi:10.1002/j.1939-4640.1996.tb00585.x · Cited by 68
Tripathy, D., Shah, P., Lakshmy, R., & Reddy, K. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978950 · Cited by 66
Freedman, D. S., O'Brien, T. R., Flanders, W. D., Destefano, F. R., & Barboriak, J. J. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.307 · Cited by 65
Tan, Shiu, Pang, & Kung (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00372.x · Cited by 65
Polycystic ovary syndrome: a risk factor for cardiovascular disease?
Rajkhowa, M., Glass, M. R., Rutherford, A. J., Michelmore, K., & Balen, A. H. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11572.x · Cited by 64
Berglund, L., Carlström, K., Stege, R., Gottlieb, C., Eriksson, M., Angelin, B., & Henriksson, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675589 · Cited by 64
Sex hormones and coronary artery disease
Chute, C. G., Baron, J. A., Plymate, S. R., Kiel, D. P., Pavia, A. T., Lozner, E. C., O'Keefe, T., & MacDonald, G. J. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90642-5 · Cited by 64
Kiechl, S. J., Willeit, J., Bonora, E., Schwarz, S., & Xu, Q. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1094 · Cited by 63
Progestin‐Androgen Combination Regimens for Male Contraception
Meriggiola, M. C., & Bremner, W. J. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01913.x · Cited by 62
Tchernof, A., Labrie, F., Bèlanger, A., & Després, J. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.150s155 · Cited by 62
Barth, J. D., Jansen, H., Hugenholtz, P. G., & Birkenhäger, J. C. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90041-2 · Cited by 62
WALKER, T. C. (1942) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-2-9-560 · Cited by 61
Sex hormone—binding globulin and insulin resistance in African-American women
Sherif, K., Kushner, H., & Falkner, B. E. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90195-0 · Cited by 61
Effect of testosterone enanthate on serum lipoproteins in man
Anderson, R. A., Wallace, E. M., & Wu, F. C. W. (1995) · Contraception · doi:10.1016/s0010-7824(95)00136-0 · Cited by 61
Self-citationvon Eckardstein, A., Kliesch, S., Nieschlag, E., Chirazi, A., Assmann, G., & Behre, H. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4267 · Cited by 61
Cardiovascular Risk in Women With Polycystic Ovarian Syndrome
Guzick, D. S. (1996) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1016308 · Cited by 60
Tan, K. C. B., Shiu, S. W. M., Pang, R. W. C., & Kung, A. W. C. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3721211.x · Cited by 60
Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease
Khaw, K. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.150s149 · Cited by 59
Dehydroepiandrosterone sulfate, diseases and mortality in a general aged population
Tilvis, R. S., Kähönen, M. A. P., & Härkönen, M. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03399633 · Cited by 59
The association of low plasma testosterone level with coronary artery disease in Chinese men
Zhao, S., & Li, X.-P. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(97)00295-7 · Cited by 58
Therapy for lowering lipoprotein (a) levels
Angelin, B. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199712000-00003 · Cited by 58
Gascón, F., Valle, M., Martos, R., Rodríguez, F. J. R., Ríos, R., Montilla, P., & Cañete, R. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430085 · Cited by 57
Lemieux, S., Lewis, G. F., Ben‐Chetrit, A., Steiner, G. A., & Greenblatt, E. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6140 · Cited by 55
Farhat, M. Y., Wolfe, R. A., Vargas, R., Foegh, M. L., & Ramwell, P. W. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199503000-00023 · Cited by 55
Modulation of Rapid Plasminogen Activator Inhibitor in Plasma by Stanozolol
Verheijen, J. H., Rijken, D. C., Chang, G. T. G., et al. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661110 · Cited by 54
The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women
Goh, H. H., Loke, D. F. M., & Ratnam, S. S. (1995) · Maturitas · doi:10.1016/0378-5122(94)00861-z · Cited by 53
Beer, N., Jakubowicz, D. J., Matt, D. W., Beer, R. M., & Nestler, J. E. (1996) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199605000-00002 · Cited by 53
Newcomer, L. M., Manson, J. E., Barbieri, R. L., Hennekens, C. H., & Stampfer, M. J. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117175 · Cited by 53
Hyperinsulinism and Its Interaction With Hyperandrogenism in Polycystic Ovary Syndrome
Sozen, I., & Arici, A. M. (2000) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200005000-00026 · Cited by 52
Pilo, R., Aharony, D., & Raz, A. (1981) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653405 · Cited by 52
Slowinska-Srzednicka, J., Malczewska, B., Srzednicki, M., Chotkowska, E., Brzezińska, A., Zgliczyński, W., Ossowski, M., Jeske, W., Zgliczyński, S., & SADOWSKI, Z. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb00871.x · Cited by 50
Labropoulos, B., Velonakis, E., Oekonomakos, P., Laskaris, J., & Katsimades, D. (2008) · Cardiology · doi:10.1159/000173490 · Cited by 50
Induction of ovulation in infertile women with hyperandrogenism and insulin resistance
Barbieri, R. L. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107627 · Cited by 50
Penotti, M., Sironi, L., Cannata, L., Viganò, P., Casini, A., Gabrielli, L., & Vignali, M. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01923-9 · Cited by 50
Chronic and acute effects of oestrogens on vascular contractility
Austin, C. E. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018100-00003 · Cited by 50
Aromatase and Sex Steroid Receptors in Human Vena Cava.
Sasano, H., Murakami, H., Shizawa, S., Satomi, S., Nagura, H., & Harada, N. (1999) · Endocrine Journal · doi:10.1507/endocrj.46.233 · Cited by 49
Su, W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3267 · Cited by 49
Sobel, B. E. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99231.x · Cited by 48
Sex hormones and lipoproteins in men
Kiel, D. P., Baron, J. A., Plymate, S. R., & Chute, C. G. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80480-2 · Cited by 48
Buckler, H. M., McElhone, K., Durrington, P. N., Mackness, M., Ludlam, C. A., & Wu, F. C. W. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00525.x · Cited by 48
Self-citation(1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171115 · Cited by 48
Low Serum Testosterone and Myocardial Infarction in Geriatric Male Inpatients
Swartz, C. M., & Young, M. A. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb01317.x · Cited by 47
Kabakçı, G., Yı́ldı́rı́r, A., Can, İ., Ünsal, İ., & Erbaş, B. (1999) · Cardiology · doi:10.1159/000006977 · Cited by 46
Schuler-Lüttmann, S., Mönnig, G., Enbergs, A., Schulte, H., BREITHARDT, G. E., Assmann, G., Kerber, S., & von Eckardstein, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.e10 · Cited by 46
Tang, J. J., Srivastava, R. A. K., Krul, E. S., Baumann, D. S., Pfleger, B., Kitchens, R. T., & Schonfeld, G. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41643-8 · Cited by 46
Lemieux, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4278 · Cited by 45
17-Ketosteroids and Arteriosclerosis*t
Kask, E. (1959) · Angiology · doi:10.1177/000331975901000504 · Cited by 43
The Therapeutic Value of Testosterone Propionate in Angina Pectoris
Levine, S. A., & LIKOFF, W. B. (1943) · New England Journal of Medicine · doi:10.1056/nejm194311182292102 · Cited by 43
Sewdarsen, M., Vythilingum, S., Jalal, I., Desai, R. K., & Becker, P. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90156-d · Cited by 42
Safety of estrogen/androgen regimens.
Simon, J. A. (2001) · PubMed · Cited by 41
Hyperandrogenicity in women—a prediabetic condition?
Björntorp, P. A. (1993) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1993.tb01016.x · Cited by 41
Tan, K. C. B., Shiu, S. W. M., & Kung, A. W. C. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00882.x · Cited by 41
Dobs, A. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1026 · Cited by 41
The Treatment of Angina Pectoris with Testosterone Propionate
Lesser, M. A. (1942) · New England Journal of Medicine · doi:10.1056/nejm194201082260203 · Cited by 40
Marques-Vidal, P. M., Siè, P., Cambou, J., Chap, H., & Perret, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.6.7775625 · Cited by 38
Büchter, D., Behre, H. M., Kliesch, S., Chirazi, A., Nieschlag, E., Assmann, G., & von Eckardstein, A. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1232561 · Cited by 38
Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterol
Franzen, J., & Fex, G. A. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90030-4 · Cited by 36
Is there a case for DHEA replacement?
Nippoldt, T. B., & Nair, K. S. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80286-3 · Cited by 36
Sex hormone levels in young Indian patients with myocardial infarction.
Sewdarsen, M., Jialal, I., Vythilingum, S., & Desai, R. K. (1986) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.6.4.418 · Cited by 36
Conway, G. S., CLARK, P. M. S., & Wong, D. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00996.x · Cited by 36
Effect of sex hormones on protamine inactivated and resistant postheparin plasma lipases
Glueck, C. J., Gartside, P. S., Fallat, R. W., & Mendoza, S. (1976) · Metabolism · doi:10.1016/0026-0495(76)90059-7 · Cited by 35
Hauner, H., Stangl, K., Burger, K., Busch, U., Blömer, H., & Pfeiffer, E. F. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01649428 · Cited by 34
Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids
Kazuhiro, A., Takemitsu, F., Fujimoto, Y., Arai, H., & Keizo, I. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90018-3 · Cited by 34
von Dehn, G., von Dehn, O., Völker, W., Langer, C., Weinbauer, G. F., Behre, H. M., Nieschlag, E., Assmann, G., & von Eckardstein, A. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-12405 · Cited by 34
Editorial: The Role of Androgens in Women
Snyder, P. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7369 · Cited by 34
̈inen, E. H. ̈. ̈., Tikkanen, H. O., Harkonen, M., Na¨veri, H., & Adlercreutz, H. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90275-9 · Cited by 34
The determination of serum estradiol, testosterone and progesterone in acute myocardial infarction.
Aksut, S., Aksüt, G., Karamehmetoğlu, A., & Oram, E. (1986) · Japanese Heart Journal · doi:10.1536/ihj.27.825 · Cited by 33
Obasanjo, I., Clarkson, T. B., & Weaver, D. S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90220-6 · Cited by 33
Taniguchi, S., Yanase, T., Kobayashi, K., Takayanagi, R., & Nawata, H. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05902-3 · Cited by 33
Effects of Sex Steroids on Hepatic and Lipoprotein Lipase Activity and mRNA in the Rat
Peinado‐Onsurbe, J., Staels, B., Vanderschueren, D., Bouillon, R., & Auwerx, J. H. (2008) · Hormone Research · doi:10.1159/000183792 · Cited by 32
Searching for answers to ethnic disparities in cardiovascular risk
Levy, D. A., & Kannel, W. B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02496-x · Cited by 30
The effect of testosterone replacement on plasma lipids and apolipoproteins
Jones, D. B., BILLET, J. S., Price, W. H., Edwards, C. R. W., Beastall, G. H., HIGGINS, B., SHEPHERD, J., Horn, D. B., Wenham, P. R., & SWEETING, V. M. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00256.x · Cited by 30
Cited by
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Self-citationMolecular and Cellular Basis of Cardiovascular Gender Differences
Mendelsohn, M. E., & Karas, R. H. (2005) · Science · doi:10.1126/science.1112062 · Cited by 1,101
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
Sabatti, C., Service, S. K., Hartikainen, A.-L., Pouta, A., Ripatti, S., Brodsky, J., Jones, C. G., Zaitlen, N. A., Varilo, T., Kaakinen, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.271 · Cited by 736
Metadata
- Authors
- Wu, F. C. W., & von Eckardstein, A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 24
- Issue
- 2
- Pages
- 183-217
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2066946777
- Cited by
- 592
- References
- 427
- FWCI
- 25.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.